Mark Hensley
Corporate Officer/Principal en VELOXIS PHARMACEUTICALS A/S .
Cargos activos de Mark Hensley
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 03/01/2019 | - |
| Ventas & Marketing | 01/04/2016 | 03/01/2019 |
Historial de carrera de Mark Hensley
Formación de Mark Hensley.
| University of North Texas | Undergraduate Degree |
Estadísticas
Internacional
| Dinamarca | 2 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Hensley
- Experiencia
